WEBINAR | Development of IEX-MS Methods for Characterization of Biopharmaceuticals in Early Phase Development
Hear from Sophie Inman from AstraZeneca who discusses charge variant analysis, early stage molecule development, challenges with material loss and profile differences, and solutions using IEX-MS.
